CareRx Corp. (CRRX) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.11 k

Shareholding (Dec 2016)

FII

0.06%

Held by 1 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Healthy long term growth as Net Sales has grown by an annual rate of 22.29%

With a growth in Net Profit of 147.14%, the company declared Outstanding results in Jun 25

Risky -

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 233 Million (Small Cap)

P/E

224.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.43

Return on Equity

0.29%

Price to Book

2.68

Revenue and Profits:

Net Sales:

91 Million

(Quarterly Results - Jun 2025)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

19.13%

6 Months

22.84%

1 Year

83.94%

2 Years

161.03%

3 Years

44.9%

4 Years

-30.53%

5 Years

-2.47%

CareRx Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

22.29%

EBIT Growth (5y)

47.50%

EBIT to Interest (avg)

0.46

Debt to EBITDA (avg)

2.68

Net Debt to Equity (avg)

0.41

Sales to Capital Employed (avg)

2.46

Tax Ratio

0.86%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.06%

ROCE (avg)

4.21%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

224

Industry P/E

Price to Book Value

2.58

EV to EBIT

30.72

EV to EBITDA

9.56

EV to Capital Employed

2.11

EV to Sales

0.72

PEG Ratio

2.13

Dividend Yield

ROCE (Latest)

6.86%

ROE (Latest)

0.29%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2016

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.01% vs -2.82% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 200.00% vs 109.09% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.40",
          "val2": "89.60",
          "chgp": "2.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.50",
          "val2": "7.40",
          "chgp": "1.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "1.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.60",
          "val2": "0.20",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.00%",
          "val2": "29.00%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.08% vs -2.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.67% vs 84.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "366.70",
          "val2": "370.70",
          "chgp": "-1.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.60",
          "val2": "27.20",
          "chgp": "-2.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "15.60",
          "chgp": "-41.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.10",
          "val2": "-2.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.50",
          "val2": "-5.40",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.30%",
          "val2": "19.50%",
          "chgp": "0.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

91.40

89.60

2.01%

Operating Profit (PBDIT) excl Other Income

7.50

7.40

1.35%

Interest

1.80

Exceptional Items

-0.40

-0.50

20.00%

Consolidate Net Profit

0.60

0.20

200.00%

Operating Profit Margin (Excl OI)

32.00%

29.00%

0.30%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.01% vs -2.82% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 109.09% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

366.70

370.70

-1.08%

Operating Profit (PBDIT) excl Other Income

26.60

27.20

-2.21%

Interest

9.20

15.60

-41.03%

Exceptional Items

-2.10

Consolidate Net Profit

-4.50

-5.40

16.67%

Operating Profit Margin (Excl OI)

20.30%

19.50%

0.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -1.08% vs -2.88% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.67% vs 84.30% in Dec 2023

All Annual Results

Company CV

About CareRx Corp.

CareRx Corp.

Pharmaceuticals & Biotechnology

CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.

Company Coordinates

Company Details

20 Eglinton Ave W , TORONTO ON : M4R 1K8

Tel: 1 416 9278400

http://www.centrichealth.ca/

Registrar Details